Mosaic vaccines elicit CD8+ T cell responses in monkeys that confer immune coverage of diverse HIV strains
- Los Alamos National Laboratory
Creation of a successful HIV vaccine will require the development of a strategy to generate cellular immunity with sufficient cross-clade breadth to deal with the extreme genetic diversity of the virus. Polyvalent mosaic immunogens derived from in silica recombination of natural strains of HIV are designed to induce cellular immune responses that maximally cover the sequence diversity of circulating virus isolates. Immunization of rhesus monkeys with plasmid DNA and recombinant vaccinia virus vaccine constructs expressing either consensus immunogens or polyvalent mosaic immunogens elicited a CD4+ T lymphocyte-biased response with comparably broad epitope-specific total T lymphocyte specificities. However, immunization with the mosaic immunogens induced HIV-specific CD8+ T lymphocyte responses with markedly greater depth and breadth. Therefore, the use of polyvalent mosaic immunogens is a promising strategy for a global vaccine for HIV.
- Research Organization:
- Los Alamos National Laboratory (LANL)
- Sponsoring Organization:
- DOE
- DOE Contract Number:
- AC52-06NA25396
- OSTI ID:
- 971295
- Report Number(s):
- LA-UR-09-06137; LA-UR-09-6137
- Journal Information:
- Journal of Science, Journal Name: Journal of Science
- Country of Publication:
- United States
- Language:
- English
Similar Records
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Expanded breadth of the T-cell response to mosaic HIV-1 envelope DNA vaccination